![]() |
Volumn 19, Issue 4, 2001, Pages 717-722
|
Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
DOXIFLURIDINE;
FLOXURIDINE;
FLUOROURACIL;
THYMIDINE PHOSPHORYLASE;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
DISEASE FREE SURVIVAL;
ENZYME IMMUNOASSAY;
ENZYMOLOGY;
FEMALE;
HUMAN;
LYMPH NODE METASTASIS;
MALE;
METABOLISM;
MIDDLE AGED;
MORTALITY;
PATHOLOGY;
STOMACH TUMOR;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
CHEMOTHERAPY, ADJUVANT;
DISEASE-FREE SURVIVAL;
FEMALE;
FLOXURIDINE;
FLUOROURACIL;
HUMANS;
IMMUNOENZYME TECHNIQUES;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
STOMACH NEOPLASMS;
SURVIVAL RATE;
THYMIDINE PHOSPHORYLASE;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 0035491772
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.19.4.717 Document Type: Article |
Times cited : (19)
|
References (0)
|